InvestSMART

Hydrix Limited (ASX:HYD)

ALERT: Price-sensitive ASX Announcement for HYD
Current share price for HYD : $0.005 -0.011 (-68.75%)+
Announcement
Release
27 Feb 2026 9:08AM
Price at Release
$0.016
Full Release
download
Summary
Hydrix Limited, an Australian-based company listed on ASX under the ticker HYD, has released a trading update and growth outlook for the first half ended 31 December 2025. The company reported strong sales momentum entering calendar year 2026, with significant contract wins totaling $3.7 million, including a first-stage development contract with SynCardia for their artificial heart. Current and new client engagements are expected to deliver approximately $40 million in future revenues over the next two to three years. Operating expenses are being managed to support revenue growth, and the company is progressing with commercial discussions for its cardiac monitoring platform, potentially establishing recurring revenue streams.
Key Points
  • $2.5 million contract with SynCardia for artificial heart development.
  • Quarter to date sales of $3.7 million, mainly from new international clients.
  • Potential future revenues of ~$40 million over 2-3 years.
  • Cash on hand is $0.6 million with support via a $2.2 million Letter of Comfort.
  • Focus on developing safety-critical medical devices.
  • Continued management of operating expenses to support growth.
  • Progress in commercial discussions for a cardiac monitoring platform.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should refer to the full announcement here for further information.